PSMAfore: Methodology, Nuances, and Implications

Oliver Sartor, MD, Mayo Clinic, explains in detail the design and methodology, specific findings, nuances, and larger implications of the PSMAfore clinical trial.

Dr. Sartor presented these results as a late-breaking abstract at the ESMO Congress 2023.

View his continued comments with Dr. Christopher Wallis on the PSMAfore Control Arm and Sequencing Considerations.